OTC · Medical - Pharmaceuticals

Gedeon Richter PLC (RGEDF) Stock

$37.85 +2.03% OTC: RGEDF Healthcare

Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. The company offers women's healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids, as well as Femtech, a digital therapeutic solution to enhance women's lives.

Valuation

MetricValue
Price$37.85
Market Cap$6.92B
P/E Ratio9.35
P/B Ratio1.47
P/S Ratio2.32
EPS (TTM)$4.05
52-Week High$45.28
52-Week Low$27.17
Dividend Yield5.58%

Financials & Margins

MetricValue
ROE16.73%
ROA13.03%
ROCE19.71%
Gross Margin67.55%
Operating Margin33.69%
Net Margin24.80%
Debt/Equity0.01
Current Ratio4.69

Annual Financials (USD)

Metric20212022202320242025
Revenue$630.6B$802.8B$805.2B$857.5B$923.4B
Operating Profit$135.8B$153.6B$217.0B$261.2B$321.8B
Net Profit$139.6B$169.1B$158.8B$239.2B$230.9B
EPS$750.65$834.96$859.72$1307.00$1263.79
Op Margin21.5%19.1%26.9%30.4%34.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.15T$1.34T$1.36T$1.60T$1.67T
Total Liabilities$222.3B$279.9B$218.6B$299.1B$278.7B
Cash$59.9B$79.7B$80.5B$135.6B$210.5B
Borrowings$25.2B$22.4B$82.5B$27.4B$35.1B

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$139.9B$184.9B$123.7B$279.4B$290.6B
Investing Cash Flow$-392.5B$-190.4B$-82.0B$-132.5B$-149.5B
Financing Cash Flow$-2.9B$-4.8B$-60.9B$-69.2B$-9.6B
Net Cash Flow$-82.4B$20.8B$-1.1B$55.1B$99.7B
Free Cash Flow$-3.4B$113.3B$61.7B$215.7B$248.3B

Valuation & Return Ratios

MetricValue
PEG Ratio-2.40
EV / EBITDA5.47
FCF Yield12.15%
Quick Ratio3.46
Interest Coverage5.81
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held25.25%
Institutions Held36.08%
Institutions Float Held48.27%
Institutional HolderSharesReport Date
Generali Investments Cee, Investicni Spolecnost, A.s.403,2522026-06-30
Pacer Advisors, Inc.40,4802026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Gedeon Richter PLC

Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. The company offers women's healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids, as well as Femtech, a digital therapeutic solution to enhance women's lives. It also provides central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and anaesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic medicines, as well as products for the prevention and treatment of various cardiovascular diseases. In addition, the company produces various over-the-counter products for various health problems comprising Panangin for heart support; Escapelle and Postinor, which are emergency contraceptive pills; Stopdiar and Nifuroxazide to treat diarrhea; RICHTER CycleBalance for infertility and PCOS; Curiosin for wound healing; Groprinosin for antiviral and immunostimulant; Folik, a pregnancy supplement; Moilec for back and joint pain; Fasconal, a pain relief tablet; Lordestin for allergies; Magnezin, a magnesium supplement; Aflamil, an anti-inflammatory and antirheumatic cream; and Oralsept, a sore throat and local anesthetic. Further, it engages in the provision of financial accounting, social and welfare, portfolio and management, catering, carriage transportation, engineering, quality control, asset management, and biotechnological manufacturing and research services; pharmaceutical retail; trading of biotech products; and sale of medical equipment. The company has strategic co-development and license agreement with Adalvo Ltd. for a proposed bioequivalent to Semaglutide injection, a GLP-1 receptor agonist indicated for chronic weight management. Additionally, it has a strategic research collaboration with FimmCyte AG for the development of first-in-class antibody, ‘FMC2', for the treatment of endometriosis. The company was founded in 1901 and is headquartered in Budapest, Hungary.

Gedeon Richter PLC is headquartered in HU.

Gedeon Richter PLC (RGEDF) stock trades at $37.85 with a market capitalization of $6.92B. The stock is valued at a price-to-earnings (P/E) ratio of 9.35, price-to-book of 1.47, price-to-sales of 2.32. Over the past 52 weeks the stock has ranged between $27.17 and $45.28, and currently trades 16.4% below its 52-week high. It pays a dividend yielding 5.58%.

On profitability, Gedeon Richter PLC generates a return on equity (ROE) of 16.73%, above the typical market average, return on capital employed of 19.71%, an operating margin of 33.69%, a net profit margin of 24.80%.

Official website: www.gedeonrichter.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides